Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
47 /100
MEDIUM RISK
Score updated Oct 13, 2026

PLYX — Polaryx Therapeutics, Inc. Dilution Risk Tracker

Track PLYX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PLYX — Get alerts when the score changes →

As of October 13, 2026, Polaryx Therapeutics, Inc. (PLYX) has a DilutionWatch DilutionScore of 47/100, rated MEDIUM dilution risk. Polaryx Therapeutics, Inc. has a market capitalization of $100.19M, 49.85M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
95
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for PLYX.
🔔 Track PLYX — Get forecast alerts →

Market Data

Market Cap$100.19M
Shares Outstanding49.85M
Float4.28M
Cash$11.54M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore47/100DilutionWatch score record
Shares Outstanding49.85MVerified float table or market cache
Public Float4.28MVerified float table or market cache
Market Cap$100.19MMarket data cache
Cash Runway35.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: 4 1, 8-K 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

4.4% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track PLYX for full holder detail →

Short Interest

Short Interest143.3K
Days to Cover4.5
% of Float3.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

8-K 8K EVENT 2026-05-28
4 INSIDER TRANSACTION 2026-05-28
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PLYX Dilution Snapshot

Polaryx Therapeutics, Inc. (PLYX) has a DilutionScore of 47/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PLYX's DilutionScore is currently 47/100 (Medium risk), with 1 score change tracked over 89 days. The score deteriorated from 64/100 (High risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202647/100MEDIUM53 days
Jul 16 – Aug 21, 202664/100HIGH36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

Share count history for PLYX is tracked from verified regulatory filings.

Date Shares Outstanding Public Float Change
May 31, 202649.85M4.28M▼ 14.21%
Apr 03, 2026—4.98M▲ 323.58%
Mar 26, 2026—1.18M▲ 0.67%
Mar 09, 2026—1.17M▼ 12.56%
Mar 05, 2026—1.34M▼ 86.63%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PLYX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PLYX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PLYX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PLYX
PLYX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.